Dorzagliatin: all 23 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Dorzagliatin in Pancreatic Insufficient Cystic FibrosisRecruitingNCT06995651Phase 1
- Glucokinase Activator in Monogenic DiabetesRecruitingNCT06976658Phase 2
- Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 DiabetesNot yet recruitingNCT06671340Not applicable
- Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.Not yet recruitingNCT06222476Not applicable
- A Multi-center 12-week Study of HMS5552 in T2DMCompletedNCT02561338Phase 2Results posted
- Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal InsufficiencyWithdrawnNCT07786571Not applicable
- A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 DiabetesCompletedNCT06263348Phase 4
- Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGTStatus unknownNCT05468229Phase 1/2
- Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase ActivityActive, not recruitingNCT05098470Phase 3
- Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic DiabetesCompletedNCT04531631Phase 2
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy VolunteersCompletedNCT04426708Phase 1
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy VolunteersCompletedNCT04324424Phase 1
- DDI Study Between Dorzagliatin and RifampicinCompletedNCT04080609Phase 1
- DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of DorzagliatinCompletedNCT04080596Phase 1
- Drug Interaction Study Between Dorzagliatin and SitagliptinCompletedNCT03790839Phase 1
- Drug Interaction Study Between Dorzagliatin and EmpagliflozinCompletedNCT03790787Phase 1
- Long-term Efficacy and Safety of HMS5552 in T2DM SubjectsCompletedNCT03173391Phase 3
- Human Mass Balance Study of HMS5552 in Healthy SubjectsCompletedNCT03158506Phase 1
- Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM SubjectsCompletedNCT03141073Phase 3
- Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DMCompletedNCT02597400Phase 1
- Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM PatientsCompletedNCT02386982Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 DiabetesCompletedNCT02077452Phase 1
- A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy VolunteersCompletedNCT01952535Phase 1